LTS Lohmann Therapie Systeme AG to present at the J.P. Morgan 36th Annual Healthcare Conference 2018 Print
By PR Newswire:   
Wednesday, 03 January 2018 08:49


J.P. Morgan 36th Annual Healthcare Conference 2018


Monday, January 8th 2018


4:00 pm (Pacific Time) 


Westin St. Francis Hotel, San Francisco, CA

About LTS Lohmann Therapie Systeme AG

LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS") and Oral Thin Films ("OTF") for the pharmaceutical industry. LTS's innovation model consists of both partner-funded and self-funded initiatives currently encompassing more than 20 marketed products and a deep and diverse pipeline of development projects targeting multiple disease indications. LTS maintains its leading position through the continuous refinement of its core TTS and OTF technologies and by advancing emerging drug delivery technologies, including Micro Array Patches for the transdermal delivery of large molecule, biological actives. Founded in 1984, LTS operates today from two sites in Andernach, Germany and West Caldwell, NJ, USA and a representation in Shanghai, China.

Media Contacts

Dr. Iris Schnitzler,
LTS Marketing und Market Services 

LTS Lohmann Therapie-Systeme AG
Lohmannstr. 2
D- 56626 Andernach
Tel.: +49 (0) 2632 99 - 2589


View original content:

SOURCE LTS Lohmann Therapie Systeme AG

Read more

BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and
investor relation services from various entities and

Error. Page cannot be displayed. Please contact your service provider for more details. (9)

firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit!! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!